ГЕПАТОПРОТЕКТОРНЫЕ ЭФФЕКТЫ ПРЕПАРАТА МЕКСИКОР ® ПРИ ЛЕЧЕНИИ БОЛЬНЫХ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И САХАРНЫМ ДИАБЕТОМ 2 ТИПА
The prospective, randomized, open-label 16-week trial studied Mexicor ® (part of complex treatment) effects in patients with chronic heart failure and type 2 diabetes mellitus, on structural and functional parameters of the liver. Hepatoprotecive facilities of Mexicor ® were demonstrated: a signific...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2013-06-01
|
| Series: | Arhivʺ Vnutrennej Mediciny |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/196 |